Peel Hunt Reiterates "Add" Rating for ConvaTec Group (LON:CTEC)

Key Points

• Peel Hunt has reaffirmed an "add" rating for ConvaTec Group (CTEC) with a target price of GBX 280 ($3.74), indicating a potential upside of 14.47% from the current stock price.
• Other analysts, including Deutsche Bank and JPMorgan Chase, have also given buy ratings, with target prices ranging from GBX 307 to GBX 315 ($4.10 to $4.21).
• ConvaTec Group's stock has a twelve-month price range between GBX 211.80 ($2.83) and GBX 311.20 ($4.16), reflecting volatility in its trading performance.

Peel Hunt reissued their add rating on shares of ConvaTec Group (LON:CTEC - Free Report) in a research report report published on Tuesday morning, Marketbeat Ratings reports. Peel Hunt currently has a GBX 280 ($3.71) target price on the stock.

CTEC has been the topic of several other research reports. JPMorgan Chase & Co. reiterated an "overweight" rating and issued a GBX 307 ($4.07) price target on shares of ConvaTec Group in a research note on Wednesday, July 9th. Deutsche Bank Aktiengesellschaft reiterated a "buy" rating and set a GBX 315 ($4.18) price target on shares of ConvaTec Group in a report on Thursday, July 3rd. Five equities research analysts have rated the stock with a buy rating, According to MarketBeat, the stock currently has an average rating of "Buy" and an average target price of GBX 303.40 ($4.02).

ConvaTec Group Stock Performance

LON:CTEC traded down GBX 13.40 ($0.18) during trading hours on Tuesday, reaching GBX 231 ($3.06). The company had a trading volume of 15,432,411 shares, compared to its average volume of 14,085,920. ConvaTec Group has a 52 week low of GBX 211.80 ($2.81) and a 52 week high of GBX 311.20 ($4.13). The firm's 50 day moving average price is GBX 272.98 and its 200-day moving average price is GBX 259.22. The company has a current ratio of 2.26, a quick ratio of 0.96 and a debt-to-equity ratio of 85.32. The firm has a market cap of £5.87 billion, a price-to-earnings ratio of 38.90, a PEG ratio of 0.93 and a beta of 0.64.

About ConvaTec Group

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns.